These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26608264)

  • 21. Limitations in the classification of childhood-onset rheumatoid arthritis.
    Ferrell EG; Ponder LA; Minor LS; Angeles-Han ST; Kennedy CW; Rouster-Stevens KA; Rohani-Pichavant M; Vogler LB; Prahalad S
    J Rheumatol; 2014 Mar; 41(3):547-53. PubMed ID: 24488421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
    De Rycke L; Verhelst X; Kruithof E; Van den Bosch F; Hoffman IE; Veys EM; De Keyser F
    Ann Rheum Dis; 2005 Feb; 64(2):299-302. PubMed ID: 15166003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients.
    Hjeltnes G; Hollan I; Førre Ø; Wiik A; Mikkelsen K; Agewall S
    Scand J Rheumatol; 2011 Nov; 40(6):422-7. PubMed ID: 22150462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity.
    Shakiba Y; Koopah S; Jamshidi AR; Amirzargar AA; Massoud A; Kiani A; Nicknam MH; Nazari B; Nikbin B
    Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):147-56. PubMed ID: 24659118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness.
    del Val del Amo N; Ibanez Bosch R; Fito Manteca C; Gutierrez Polo R; Loza Cortina E
    Clin Exp Rheumatol; 2006; 24(3):281-6. PubMed ID: 16870095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.
    Lee AN; Beck CE; Hall M
    Clin Lab Sci; 2008; 21(1):15-8. PubMed ID: 18335856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological markers in inflammatory bowel disease: practical consideration for clinicians.
    Mendoza JL; Abreu MT
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S158-73. PubMed ID: 20117339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laboratory markers in IBD: useful, magic, or unnecessary toys?
    Vermeire S; Van Assche G; Rutgeerts P
    Gut; 2006 Mar; 55(3):426-31. PubMed ID: 16474109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low prevalence of antibodies to cyclic citrullinated peptide in patients with inflammatory bowel disease regardless of the presence of arthritis.
    Papamichael K; Tsirogianni A; Papasteriades C; Mantzaris GJ
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):705-9. PubMed ID: 19525851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.
    Brunner JK; Sitzmann FC
    Mod Rheumatol; 2006; 16(6):372-5. PubMed ID: 17164999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptidyl-arginine deiminase: an additional marker of rheumatoid arthritis.
    Basu PS; Majhi R; Ghosal S; Batabyal SK
    Clin Lab; 2011; 57(11-12):1021-5. PubMed ID: 22239037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment.
    Lal P; Su Z; Holweg CT; Silverman GJ; Schwartzman S; Kelman A; Read S; Spaniolo G; Monroe JG; Behrens TW; Townsend MJ
    Arthritis Rheum; 2011 Dec; 63(12):3681-91. PubMed ID: 22127691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunodiagnostic significance of anti-RA33 autoantibodies in Saudi patients with rheumatoid arthritis.
    Al-Mughales JA
    J Immunol Res; 2015; 2015():604305. PubMed ID: 25883991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calprotectin (a major leucocyte protein) is associated with the levels of anti-CCP and rheumatoid factor in a longitudinal study of patients with very early rheumatoid arthritis.
    Hammer HB; Haavardsholm EA; Kvien TK
    Scand J Rheumatol; 2008; 37(3):179-82. PubMed ID: 18465451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of selected biomarkers, polymorphisms, and clinical features for oligoarticular juvenile idiopathic arthritis-associated uveitis.
    Pelegrín L; Casaroli-Marano R; Antón J; García de Vicuña MC; Molina-Prat N; Ignacio Aróstegui J; Yagüe J; Ríos J; Adán A
    Ocul Immunol Inflamm; 2014 Jun; 22(3):208-12. PubMed ID: 24131380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of homocysteine with immunological-inflammatory and metabolic laboratory markers and factors in relation to hyperhomocysteinaemia in rheumatoid arthritis.
    Yang X; Gao F; Liu Y
    Clin Exp Rheumatol; 2015; 33(6):900-3. PubMed ID: 26690891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.
    Kasapçopur O; Altun S; Aslan M; Karaarslan S; Kamburoglu-Göksel A; Saribas S; Arisoy N; Kocazeybek B
    Ann Rheum Dis; 2004 Dec; 63(12):1687-9. PubMed ID: 15547097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
    Manivel VA; Mullazehi M; Padyukov L; Westerlind H; Klareskog L; Alfredsson L; Saevarsdottir S; Rönnelid J
    Ann Rheum Dis; 2017 Sep; 76(9):1529-1536. PubMed ID: 28336519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study.
    Syversen SW; Gaarder PI; Goll GL; Ødegård S; Haavardsholm EA; Mowinckel P; van der Heijde D; Landewé R; Kvien TK
    Ann Rheum Dis; 2008 Feb; 67(2):212-7. PubMed ID: 17526555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.